Literature DB >> 11087665

Characterization of PSKH1, a novel human protein serine kinase with centrosomal, golgi, and nuclear localization.

G Brede1, J Solheim, G Tröen, H Prydz.   

Abstract

We report here the characterization of PSKH1, a novel human protein serine kinase with multiple intracellular localizations. The gene consists of three exons distributed over 35 kb of genomic DNA in region 16q22.1. The 3.4-kb cDNA predicts a protein of 424 amino acids with a calculated molecular mass of 48.1 kDa and pI of 9.6. PSKH1 is expressed in all tissues and cell lines tested as shown by Northern blots, with the highest level of abundance in testis. PSKH1 displays the highest level of similarity with rat CaM kinase I (50. 2%) over 259 amino acids in the conserved catalytic region, but lacks significant homology with proteins in the database outside the catalytic core. Polyclonal antibodies have been raised, and indirect immunofluorescence microscopy of untransfected COS-1 cells suggests that PSKH1 is localized in the Brefeldin A-sensitive Golgi compartment, at centrosomes, in the nucleus with a somewhat speckle-like presence, and more diffusely in the cytoplasm. The presence in the centrosome appears to be enhanced during osmotic stress. Immunoisolated PSKH1 does not phosphorylate any of the common kinase substrates in vitro, but autophosphorylates exclusively serines within its COOH-terminal region in an intermolecular fashion. Furthermore, autophosphorylation activity is repressed upon addition of Ca(2+)/CaM, suggesting that PSKH1 activity depends on Ca(2+) concentration in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087665     DOI: 10.1006/geno.2000.6365

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  PSKH1, a novel splice factor compartment-associated serine kinase.

Authors:  Gaute Brede; Jorun Solheim; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Merete T Wiiger; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

3.  Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan.

Authors:  Seung Tae Kim; Tae Jin Ahn; Eunjin Lee; In-Gu Do; Su Jin Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Suk Hyeong Kim; Jeeyun Lee; Hee Cheol Kim
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

Review 4.  Golgi Structure and Function in Health, Stress, and Diseases.

Authors:  Jie Li; Erpan Ahat; Yanzhuang Wang
Journal:  Results Probl Cell Differ       Date:  2019

5.  MiR-566 mediates cell migration and invasion in colon cancer cells by direct targeting of PSKH1.

Authors:  Ying Zhang; Siqi Zhang; Jian Yin; Ruisi Xu
Journal:  Cancer Cell Int       Date:  2019-12-11       Impact factor: 5.722

Review 6.  Cataloguing the dead: breathing new life into pseudokinase research.

Authors:  Safal Shrestha; Dominic P Byrne; John A Harris; Natarajan Kannan; Patrick A Eyers
Journal:  FEBS J       Date:  2020-03-10       Impact factor: 5.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.